Dr. Sudhir Agrawal

Scientific Advisor

Dr. Sudhir Agrawal, FRSC is founder and President of ARNAY Sciences LLC. He is also serving as visiting professor in the department of medicine at University of Massachusetts Medical School, and a member of the business advisory board of Harvard Medical School’s Initiative for RNA Medicine. He is currently serving as a member of the scientific advisory boards of several biotechnology companies. He is also a founder of Idera Pharmaceuticals and has had held various leadership roles within the company, including Chairman, CEO, President of Research, and Chief Scientific Officer until 2017. Over the last three decades, his research has been focused on the discovery and development of RNA therapeutics. He has published over 300 research papers and is listed as a co-inventor of more than 400 patents worldwide. He has edited four books on oligonucleotides and antisense technology, including a recent book on ‘Advances in Nucleic Acid Therapeutics’ published 2019 by The Royal Society of Chemistry.